When Therapy Doesn’t Work: Why People Turn to Psychedelic-Assisted Therapy
Conventional treatment for depression, anxiety, and PTSD fails a substantial minority of people, and the odds of remission drop with each medication that does not work....
Psilocybin PTSD Treatment: Where the Research Stands in 2026
Psilocybin PTSD treatment is still investigational. The strongest evidence so far is a single small open-label trial of 22 people, which showed meaningful symptom reductions but...
Microdosing for Depression and Anxiety: What the Clinical Evidence Actually Shows
Placebo-controlled trials of microdosing have consistently failed to show that low doses of psilocybin or LSD outperform placebo for mood, anxiety, or well-being. People taking a...
Psychedelics and Trauma: How These Medicines Work at the Neurological Level
Psychedelics appear to address trauma by temporarily increasing the brain’s capacity to change, opening a window in which fear-based memories become editable rather than fixed. The...
Psilocybin Anxiety Treatment: What the Research Shows
Psilocybin anxiety treatment has produced large, lasting reductions in anxiety across controlled trials, first in people facing cancer-related distress and more recently in generalized anxiety disorder....
The Best Psychedelic for Addiction? Comparing Ibogaine, Psilocybin, Ketamine, Ayahuasca
There is no single best psychedelic for addiction, because the evidence is organized by which substance you are trying to stop. Psilocybin has the strongest controlled-trial...
The Best Psychedelic for PTSD? Comparing MDMA, Psilocybin, and Ketamine
MDMA-assisted therapy has the strongest evidence of any psychedelic for PTSD, with two completed Phase 3 trials showing that a majority of participants no longer met...
The Best Psychedelic for Depression? Psilocybin vs Ketamine vs LSD vs Ayahuasca
There is no single best psychedelic for depression, but the evidence is not evenly distributed. Ketamine has the strongest legal access and the fastest onset, psilocybin...
5-MeO-DMT for Depression and Anxiety: What the Evidence Shows
Research on 5-MeO-DMT for depression and anxiety, particularly in the context of 5-MeO-DMT depression anxiety treatment, is genuinely early, but it is no longer purely anecdotal....
Addiction Psychedelic Therapy: What the Science Says About Breaking the Cycle
Early clinical research on addiction and psychedelic therapy is genuinely promising, with controlled trials showing meaningful reductions in heavy drinking and high abstinence rates in tobacco...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.